Postpartum depression pill safe & effective: Study
image for illustrative purpose
New York: A pill used for postpartum depression (PPD) is safe for use and has shown to be effective in managing symptoms, results of a new study has shown. PPD is a common perinatal complication experienced by one in eight women and has adverse maternal and infant outcomes.
Zuranolone, developed by Sage Therapeutics and Biogen, is an oral, once-daily neuroactive steroid pill used in a 14-day treatment course for patients with severe PPD.
“In the trial, zuranolone demonstrated significant improvements in depressive symptoms and was generally well tolerated, supporting the potential of zuranolone as a novel, rapid-acting oral treatment for PPD,” said researchers of the trial published in The American Journal of Psychiatry.
About 57 per cent of the women taking zuranolone experienced a 50 per cent or more improvement in their depressive symptoms at day 15, versus 38 per cent of women taking placebo.
